Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05857995

Precision Lung Cancer Survivorship Care Intervention

Led by Jerod L Stapleton, PhD · Updated on 2026-02-23

300

Participants Needed

1

Research Sites

189 weeks

Total Duration

On this page

Sponsors

J

Jerod L Stapleton, PhD

Lead Sponsor

U

University of Louisville

Collaborating Sponsor

AI-Summary

What this Trial Is About

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.

CONDITIONS

Official Title

Precision Lung Cancer Survivorship Care Intervention

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have been diagnosed with lung cancer
  • Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
  • Be at least 18 years of age or older
  • Be able to communicate effectively in English
Not Eligible

You will not qualify if you...

  • Have significant psychiatric disturbance that requires a higher level of care
  • Have substance abuse/dependence that requires a higher level of care
  • Are participating in another lung cancer survivorship care intervention
  • Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Markey Cancer Center

Lexington, Kentucky, United States, 40536

Actively Recruiting

Loading map...

Research Team

J

Jerod L Stapleton, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here